Bioventus
BVS
134 hedge funds and large institutions have $320M invested in Bioventus in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 27 reducing their positions, and 31 closing their positions.
592% more call options, than puts
Call options by funds: $595K | Put options by funds: $86K
141% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 27
1.61% more ownership
Funds ownership: 71.31% → 72.92% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less funds holding
Funds holding: 144 → 134 (-10)
29% less capital invested
Capital invested by funds: $448M → $320M (-$128M)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$8.19M |
| 2 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
+$2.48M |
| 3 |
Millennium Management
New York
|
+$2.25M |
| 4 |
BlackRock
New York
|
+$2.17M |
| 5 |
KOCAA
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
+$2.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$13.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.94M |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$4.34M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.32M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.74M |
BVS Hedge Fund Activity: Q2 2025 in Review
134 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q2 2025, worth a combined $320M — down 29% from $448M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of BVS and 22 opened new positions — a net loss of 9 holders — while 27 trimmed existing stakes and 65 added.
The largest buyer was Nantahala Capital Management, adding an estimated $8.19M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $13.2M sold.
- 134 institutional investors held Bioventus (BVS) as of Q2 2025, down from 144 in Q1 2025.
- Funds reported $320M of Bioventus stock for Q2 2025, down 29% quarter-over-quarter.
- 22 funds opened new Bioventus positions in Q2 2025 and 31 closed out, a net change of -9 holders.
- The largest Bioventus buyer in Q2 2025 was Nantahala Capital Management, an estimated $8.19M added.
- The largest Bioventus seller in Q2 2025 was Driehaus Capital Management, an estimated $13.2M sold.
Based on aggregated 13F filings for Q2 2025.